Cargando…

Heart rate variability and adrenal size provide clues to sudden cardiac death in hospitalized COVID-19 patients

PURPOSE: To examine the association between a measure of heart rate variability and sudden cardiac death (SCD) in COVID-19 patients. METHODS: Patients with SARS-COV-2 infection admitted to Columbia University Irving Medical Center who died between 4/25/2020 and 7/14/2020 and had an autopsy were exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranard, Benjamin L., Megjhani, Murad, Terilli, Kalijah, Yarmohammadi, Hirad, Ausiello, John, Park, Soojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291038/
https://www.ncbi.nlm.nih.gov/pubmed/35863211
http://dx.doi.org/10.1016/j.jcrc.2022.154114
Descripción
Sumario:PURPOSE: To examine the association between a measure of heart rate variability and sudden cardiac death (SCD) in COVID-19 patients. METHODS: Patients with SARS-COV-2 infection admitted to Columbia University Irving Medical Center who died between 4/25/2020 and 7/14/2020 and had an autopsy were examined for root mean square of successive differences (RMSSD), organ weights, and evidence of SCD. RESULTS: Thirty COVID-19 patients were included and 12 had SCD. The RMSSD over 7 days without vs with SCD was median 0.0129 (IQR 0.0074–0.026) versus 0.0098 (IQR 0.0056–0.0197), p < 0.0001. The total adjusted adrenal weight of the non-SCD group was 0.40 g/kg (IQR 0.35–0.55) versus 0.25 g/kg (IQR 0.21–0.31) in the SCD group, p = 0.0007. CONCLUSIONS: Hospitalized patients with COVID-19 who experienced SCD had lower parasympathetic activity (RMSSD) and smaller sized adrenal glands. Further research is required to replicate these findings.